Formulary Chapter 13: Skin - Full Chapter
|
Chapter Links... |
APC Psoriasis Guideline (Adults & Children) |
Atopic Dermatitis Treatment Algorithm for High Cost Drugs |
Psoriasis Treatment Algorithm for High Cost Drugs |
Specials recommended by the British Association of Dermatologist (BAD) |
Details... |
13.10.04 |
Parasiticidal preparations |
|
|
Benzyl Benzoate Application BP 25%
|
Formulary
|
Application Less suitable for prescribing (BNF) Not recommended for treatment of scabies in local guidance Not recommended for children — dilution to reduce irritant effect also reduces efficacy. Some manufacturers recommend application to the body but to exclude the head and neck. However, application should be extended to the scalp, neck, face, and ears (BNF)
|
|
Cyclomethicone 50% / Isopropyl myristate 50% solution (Full Marks solution)
|
Formulary
|
Solution
- May be prescribed if appropriate to in-patients; patients should be advised on discharge that further supply should be purchased
|
|
Dimeticone (Hedrin®)
|
Formulary
|
Lotion 4%
- May be prescribed if appropriate to in-patients; patients should be advised on discharge that further supply should be purchased
|
|
Ivermectin
|
Restricted
|
Tablets 3 mg,6mg
- Unlicensed medicine - named patient use only
- Dermatology specialist only
|
Link to reviews
NICE Evidence summary: Ivermectin for difficult-to-treat scabies
|
Malathion 0.5% (Derbac-M®)
|
Formulary
|
Aqueous solution 150mL
- May be prescribed if appropriate to in-patients; patients should be advised on discharge that further supply should be purchased
|
|
Permethrin 5% (Lyclear® Dermal Cream)
|
Formulary
|
Dermal Cream 30g (generic available)
- May be prescribed if appropriate to in-patients; patients should be advised on discharge that further supply should be purchased
|
|
Permethrin 1% (Lyclear® Creme Rinse)
|
Restricted
|
Cream Rinse
- May be prescribed if appropriate to in-patients; patients should be advised on discharge that further supply should be purchased
|
|
|
|
|
|
|
.... |
Non Formulary Items |
Phenothrin

|
Non Formulary
|
Discontinued |
|
|
Key |
|
|
Cytotoxic Drug
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
Traffic Light Status Information
Status |
Description |

|
Grey / Non-Formulary: Medicines, which the Nottinghamshire APC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.
Grey / Non-Formulary (undergoing assessment): Work is ongoing and will be reviewed at a future APC meeting.
Grey / Non-Formulary (no formal assessment): APC has not formally reviewed this medicine or indication because it had never been requested for formulary inclusion. Often used for drugs new to market. |

|
Medicines which should normally be prescribed by specialists only. eg hospital only.
For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care. |

|
Medicines that should be initiated by a specialist and prescribed by primary care prescribers only under a shared care protocol, once the patient has been stabilised.
Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the Nottinghamshire APC. |

|
Medicines suitable to be prescribed in primary care / general practice after specialist* recommendation or initiation.
A supporting prescribing guideline may be requested which must have been agreed by the relevant secondary care trust DTCs and approved by the Nottinghamshire APC.
*Specialist is defined by the APC as a clinician who has undertaken an appropriate formal qualification or recognised training programme within the described area of practice |

|
Primary care/ non specialist may initiate as per APC guideline.
The supporting prescribing guideline must have been agreed by the relevant secondary care trust D&TC(s) and approved by the Nottinghamshire APC. |

|
Medicines suitable for routine use within primary care.
Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing. |

|
|
|
|
|